Galux raises $29M Series B to scale AI-driven protein design ...

AMBER Tx General

Strategy Notes

Keyword match: +4 relevant, -1 negative signals.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: —
Type: unknown
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-09 OPEN → INELIGIBLE · This is a news article reporting that Galux (a South Korean biotech startup) raised $29M in Series B venture capital. It is not a funding opportunity, grant, fellowship, or programme that accepts applications. There is no mechanism for Eniola or any external applicant to apply.